Reuters logo
3 months ago
BRIEF-Newron Pharmaceuticals receives 11.3 million euros milestone payments for US approval of Xadago
May 12, 2017 / 5:12 AM / 3 months ago

BRIEF-Newron Pharmaceuticals receives 11.3 million euros milestone payments for US approval of Xadago

May 12 (Reuters) - NEWRON PHARMACEUTICALS SPA:

* RECEIVES EUR11.3M MILESTONE PAYMENTS FOR U.S. APPROVAL OF XADAGO (SAFINAMIDE) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below